Crinetics Pharmaceuticals to Announce Q1 2024 Financial Results on May 9, 2024
SAN DIEGO, May 02, 2024 -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) has scheduled the release of its first quarter financial results for 2024 on Thursday, May 9, 2024, subsequent to the closing of U.S. financial markets. Following this, company management will hold a conference call at 4:30 p.m. Eastern Time to discuss the financial outcomes and provide a business update.
Details for the conference call are as follows:
- Date and Time: Thursday, May 9th at 4:30 PM ET
- Domestic Dial-in: 1-888-886-7786
- International Dial-in: 1-416-764-8658
- Conference ID: 71864759
Participants have the option to dial in using the provided numbers and will be greeted by an operator. Alternatively, they can utilize the Call me™ link for immediate telephone access to the event:
Call me™: https://emportal.ink/3xjDV8X
About Crinetics Pharmaceuticals
Crinetics Pharmaceuticals is a clinical-stage company dedicated to the discovery, development, and commercialization of innovative therapies for endocrine diseases and endocrine-related tumors. The company’s lead product, Paltusotine, is an investigational oral somatostatin receptor type 2 (SST2) agonist currently undergoing Phase 3 clinical trials for acromegaly and Phase 2 trials for carcinoid syndrome related to neuroendocrine tumors.
Another significant candidate, CRN04894, is an investigational oral ACTH antagonist with first-in-class status. It has shown pharmacologic proof-of-concept in a Phase 1 clinical study and is now in Phase 2 clinical development targeting congenital adrenal hyperplasia and Cushing’s disease.
Crinetics' portfolio consists of orally delivered, small molecule new chemical entities generated through internal drug discovery initiatives. Their research extends to various endocrine conditions, including hyperparathyroidism, polycystic kidney disease, Graves’ disease, thyroid eye disease, diabetes, and obesity.
How to obtain the latest research advancements in the field of biopharmaceuticals?
In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!
